Jeff Martin
Stock Analyst at Roth Capital
(3.50)
# 934
Out of 5,090 analysts
64
Total ratings
60%
Success rate
16.64%
Average return
Main Sectors:
Stocks Rated by Jeff Martin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSIS OSI Systems | Maintains: Buy | $280 → $292 | $266.00 | +9.77% | 17 | Dec 1, 2025 | |
| PERI Perion Network | Reiterates: Buy | $14 → $15 | $9.98 | +45.29% | 10 | Nov 13, 2025 | |
| NSP Insperity | Maintains: Buy | $85 → $74 | $35.14 | +110.59% | 9 | Aug 4, 2025 | |
| FC Franklin Covey Co. | Maintains: Buy | $30 → $27 | $15.89 | +69.92% | 8 | Jul 7, 2025 | |
| TACT TransAct Technologies | Maintains: Buy | $6 → $5 | $4.41 | +13.38% | 1 | May 14, 2025 | |
| BGSF BGSF, Inc. | Maintains: Buy | $12 → $9 | $4.51 | +99.56% | 1 | Mar 20, 2025 | |
| BBSI Barrett Business Services | Maintains: Buy | $43 → $45 | $34.53 | +30.32% | 5 | Nov 7, 2024 | |
| HCKT The Hackett Group | Maintains: Buy | $29 → $30 | $19.43 | +54.40% | 6 | Nov 5, 2024 | |
| BWMN Bowman Consulting Group | Maintains: Buy | $47 → $43 | $33.37 | +28.86% | 5 | Aug 8, 2024 | |
| GLMD Galmed Pharmaceuticals | Initiates: Buy | $5,760 | $1.12 | +514,185.71% | 2 | Nov 15, 2017 |
OSI Systems
Dec 1, 2025
Maintains: Buy
Price Target: $280 → $292
Current: $266.00
Upside: +9.77%
Perion Network
Nov 13, 2025
Reiterates: Buy
Price Target: $14 → $15
Current: $9.98
Upside: +45.29%
Insperity
Aug 4, 2025
Maintains: Buy
Price Target: $85 → $74
Current: $35.14
Upside: +110.59%
Franklin Covey Co.
Jul 7, 2025
Maintains: Buy
Price Target: $30 → $27
Current: $15.89
Upside: +69.92%
TransAct Technologies
May 14, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $4.41
Upside: +13.38%
BGSF, Inc.
Mar 20, 2025
Maintains: Buy
Price Target: $12 → $9
Current: $4.51
Upside: +99.56%
Barrett Business Services
Nov 7, 2024
Maintains: Buy
Price Target: $43 → $45
Current: $34.53
Upside: +30.32%
The Hackett Group
Nov 5, 2024
Maintains: Buy
Price Target: $29 → $30
Current: $19.43
Upside: +54.40%
Bowman Consulting Group
Aug 8, 2024
Maintains: Buy
Price Target: $47 → $43
Current: $33.37
Upside: +28.86%
Galmed Pharmaceuticals
Nov 15, 2017
Initiates: Buy
Price Target: $5,760
Current: $1.12
Upside: +514,185.71%